AI制药行业动态点评:晶泰控股收到5100万美金首付款 AI制药商业模式得到验证

山西证券
Aug 12, 2025

事件:晶泰控股于2025 年6 月宣布与美国生物制药公司DoveTree 签定战略合作协议,利用AI+机器人药物发现平台为后者开发肿瘤、免疫炎症等领域的候选药物(小分子及抗体类),并于8 月5 日获得5100 万美元的首付款,后续可获4900 万美元付款及最高58.9 亿美元里程碑款项,另享个位数百分比的销售分成。DoveTree 获得全球独家商业化权利,该合作体现了AI制药企业商业化落地的加速。...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10